Evaluation of Potential Off-label Use of Dabigatran Etexilate in Europe

CompletedOBSERVATIONAL
Enrollment

36,573

Participants

Timeline

Start Date

November 28, 2014

Primary Completion Date

May 20, 2016

Study Completion Date

May 20, 2016

Conditions
Atrial Fibrillation
Trial Locations (1)

Unknown

1160.144.1 Boehringer Ingelheim Investigational Site, Barcelona

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY